Portfolio of Seven Marketed Oncology Injectable Products from Spectrum Pharmaceuticals to be Acquired by Acrotech Biopharma 글 내용 전체보기
Obsidian Therapeutics Announces Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors 글 내용 전체보기
Tilray® to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestones 글 내용 전체보기
Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease 글 내용 전체보기
Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome 글 내용 전체보기
Concert Pharmaceuticals Completes Enrollment of 12 mg Cohort in Phase 2a Trial of CTP-543 in Alopecia Areata 글 내용 전체보기
The Pill Club Raises $51 Million to Expand Birth Control Delivery and Prescription Services to Women Across the Country 글 내용 전체보기
Incyte Announces First Patient Treated in Phase 3 Clinical Trial of Itacitinib for Chronic Graft-Versus-Host Disease 글 내용 전체보기
